1-octanol has been researched along with mefenamic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
Fang, L; Kobayashi, D; Morimoto, Y; Numajiri, S | 1 |
Bunjes, H; Kupetz, E | 1 |
3 other study(ies) available for 1-octanol and mefenamic acid
Article | Year |
---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid.
Topics: 1-Octanol; Adjuvants, Pharmaceutic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Compounding; Ethanolamine; Ethanolamines; In Vitro Techniques; Male; Mefenamic Acid; Models, Biological; Propanolamines; Rats; Rats, Inbred Strains; Skin Absorption; Solubility; Water | 2003 |
Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
Topics: 1-Octanol; Amphotericin B; Chemistry, Pharmaceutical; Curcumin; Dibucaine; Drug Carriers; Emulsifying Agents; Emulsions; Fenofibrate; Mefenamic Acid; Nanoparticles; Particle Size; Poloxamer; Porphyrins; Propofol; Solubility; Triglycerides; Water | 2014 |